Teknologi Kesehatan
Perusahaan Argentina yang terlibat dalam satu sektor: teknologi kesehatan
Perusahaan Argentina ini beroperasi di sektor yang sama, teknologi kesehatan. Mereka dilengkapi dengan harga, perubahan, dan statistik lainnya untuk membantu anda dalam mendapatkan detail maksimal. Daftar ini berisi saham-saham untuk strategi apa pun: mulai dari raksasa dengan kapitalisasi besar seperti ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD), pelaba teratas seperti ABBOTT LABORATORIES CEDEAR EAC 4 REP 1(USD), dan masih banyak lagi. Filter daftar ini dan periksa kinerja perusahaan-perusahaan tersebut dengan cara yang nyaman.
Simbol | Kap Pasar | Harga | Perubahan % | Volume | Volume Relatif | P/E | EPS terdilusi TTM | Pertumbuhan EPS terdilusi TTM YoY | Imbal hasil dividen % TTM | Penilaian Analis |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD)DR | 780,74 T ARS | 14,500 USD | +2,11% | 409 | 0,88 | 112,53 | 124,85 ARS | +178,70% | 0,33% | — |
| LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 DR | 780,74 T ARS | 16.400,000 ARS | +1,71% | 4,96 K | 0,73 | 131,35 | 124,85 ARS | +564,33% | 0,33% | — |
 JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD)DR | 370,14 T ARS | 9,960 USD | −0,10% | 737 | 0,45 | 29,13 | 352,44 ARS | +130,17% | 1,71% | — |
| JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 370,14 T ARS | 11.450,000 ARS | −1,51% | 33,5 K | 0,51 | 32,49 | 352,44 ARS | +193,52% | 1,71% | — |
| DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 370,14 T ARS | 1.270,000 ARS | −3,42% | 2 | 0,15 | — | — | — | — | — |
 ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD)DR | 315,12 T ARS | 18,000 USD | +3,75% | 131 | 2,25 | 7,44 | 2.343,37 ARS | +18,73% | 1,77% | — |
| ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COM DR | 315,12 T ARS | 19.900,000 ARS | −1,49% | 843 | 0,75 | 8,49 | 2.343,37 ARS | +183,01% | 1,77% | — |
 MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD)DR | 253,1 T ARS | 19,700 USD | −1,50% | 65 | 0,96 | 21,61 | 883,37 ARS | +319,19% | 1,66% | — |
| MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50) DR | 253,1 T ARS | 22.500,000 ARS | −1,64% | 12,77 K | 4,81 | 25,47 | 883,37 ARS | +899,22% | 1,66% | — |
 TMOTHERMO FISHER SCIENTIFIC INC CEDEAR EACH 22 REP 1DR | 230,23 T ARS | 30.750,000 ARS | −0,16% | 55 | 0,14 | 55,01 | 558,94 ARS | +251,94% | 0,14% | — |
 ABTDABBOTT LABORATORIES CEDEAR EAC 4 REP 1(USD)DR | 227,08 T ARS | 32,500 USD | +4,84% | 58 | 2,97 | 18,10 | 1.850,70 ARS | +490,19% | 0,85% | — |
| ABTABBOTT LABORATORIES CEDEAR EACH 4 REP 1 DR | 227,08 T ARS | 36.600,000 ARS | +1,04% | 474 | 0,33 | 19,78 | 1.850,70 ARS | +652,64% | 0,85% | — |
 AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD)DR | 221,55 T ARS | 34,950 USD | +1,16% | 4 | 0,15 | 49,96 | 677,80 ARS | +64,44% | 1,42% | — |
| AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 DR | 221,55 T ARS | 40.400,000 ARS | −0,37% | 2,18 K | 2,84 | 59,60 | 677,80 ARS | +291,99% | 1,42% | — |
 ISRGINTUITIVE SURGICAL INC CEDEAR EACH 90 REP 1 ORDDR | 217,83 T ARS | 7.680,000 ARS | −6,57% | 518 | 1,65 | 117,24 | 65,51 ARS | +275,06% | 0,00% | — |
 NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD)DR | 206,17 T ARS | 25,300 USD | −0,39% | 1 | 0,31 | 2,83 | 8.672,72 ARS | +140,89% | 3,66% | — |
| NVSNOVARTIS AG CEDEAR EACH 4 REP 1 DR | 206,17 T ARS | 29.300,000 ARS | −1,18% | 47 | 0,22 | 3,38 | 8.672,72 ARS | +474,20% | 3,66% | — |
 DHRDANAHER CORP CEDEAR EACH 54 REP 1 ORDDR | 185,9 T ARS | 5.320,000 ARS | −0,56% | 304 | 0,92 | 72,12 | 73,76 ARS | +137,74% | 0,19% | — |
 AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD)DR | 155,02 T ARS | 9,300 USD | +1,09% | 5 | 0,10 | 36,18 | 249,09 ARS | −50,42% | 2,28% | — |
| AMGNAMGEN INC CEDEAR EACH 30 REP 1 DR | 155,02 T ARS | 10.725,000 ARS | −1,38% | 2,67 K | 0,61 | 43,06 | 249,09 ARS | +18,17% | 2,28% | — |
 PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD)DR | 154,82 T ARS | 6,620 USD | −1,49% | 1,25 K | 0,57 | 27,33 | 234,71 ARS | +35,96% | 3,24% | — |
| PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05 DR | 154,82 T ARS | 7.640,000 ARS | −2,55% | 11,47 K | 0,43 | 32,55 | 234,71 ARS | +224,10% | 3,24% | — |
 BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 USDDR | 126,72 T ARS | 20,300 USD | +4,10% | 5 | 0,53 | — | −1.078,84 ARS | −253,68% | 1,98% | — |
| BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 126,72 T ARS | 23.325,000 ARS | −0,32% | 2,32 K | 4,90 | — | −1.078,84 ARS | −466,33% | 1,98% | — |
 GILDDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 SHS (USD)DR | 121,46 T ARS | 24,500 USD | +0,41% | 2 | 0,29 | — | −50,65 ARS | −107,71% | 1,67% | — |
| GILDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 COM USD0.001 DR | 121,46 T ARS | 27.225,000 ARS | −0,91% | 29 | 0,07 | — | −50,65 ARS | −118,38% | 1,67% | — |
 MDTMEDTRONIC PLC CEDEAR EACH 4 REP 1DR | 121,1 T ARS | 26.350,000 ARS | −0,28% | 357 | 0,53 | 39,18 | 672,48 ARS | +274,72% | 1,87% | — |
 GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD)DR | 71,58 T ARS | 8,580 USD | −3,38% | 20 | 0,25 | 27,01 | 307,84 ARS | −37,30% | 3,15% | — |
| GSKGSK PLC CEDEAR EACH REPR 1/4 ADR DR | 71,58 T ARS | 10.025,000 ARS | −0,74% | 745 | 1,22 | 32,57 | 307,84 ARS | +49,45% | 3,15% | — |
 PHGKONINKLIJKE PHILIPS NV CEDEAR EACH REPR 1/5 ADRDR | 26,05 T ARS | 6.320,000 ARS | −0,16% | 470 | 0,29 | — | −689,04 ARS | −3,81% | 0,00% | — |
 BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD)DR | 22,31 T ARS | 11,600 USD | +0,43% | 40 | 3,51 | 16,16 | 695,64 ARS | +96,62% | 0,00% | — |
| BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005 DR | 22,31 T ARS | 13.075,000 ARS | +0,19% | 479 | 0,74 | 18,80 | 695,64 ARS | +368,68% | 0,00% | — |
 MRNADMODERNA INC CEDEAR EACH 19 REP 1 ORD (USD)DR | 16,69 T ARS | 2,230 USD | +0,90% | 242 | 0,99 | — | −262,17 ARS | +31,39% | 0,00% | — |
| MRNAMODERNA INC CEDEAR EACH 19 REP 1 ORD DR | 16,69 T ARS | 2.525,000 ARS | −2,13% | 80,98 K | 1,14 | — | −262,17 ARS | −63,54% | 0,00% | — |
 RICHLABORATORIOS RICHMOND SACIF | 138,89 B ARS | 1.720,000 ARS | 0,00% | 2,15 K | 0,19 | 17,86 | 96,29 ARS | — | 0,00% | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 4,6 B ARS | 108,000 ARS | 0,00% | 11,95 K | 3,24 | 25,30 | 4,27 ARS | +64,50% | 0,00% | — |